Mucosal and systemic immunity against poliovirus in mice transgenic for the poliovirus receptor: The poliovirus receptor is necessary for a virus- specific mucosal IgA response

Journal of Infectious Diseases

Volumn 181, Issue 3, 2000, Pages 815-823

  Buisman, A M ^a   Sonsma, J A J ^a   Kimman, T G ^a   Koopmans, M P G ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS RECEPTOR;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; MICE, TRANSGENIC; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; RECEPTORS, VIRUS;

EID: 0034088697     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315326     Document Type: Article

References (42)

1. 1. Bodian D. Emerging concept of poliomyelitis infection. Science 1955; 122: 105-8.
2. 2. McBean AM, Thoms ML, Albrecht P, Cuthie JC, Bernier R. The serologic response to oral polio vaccine and enhanced potency inactivated polio vaccine. Am J Epidemiol 1988; 128:615-28.
3. 3. Faden H, Modlin JF, Thoms ML, et al. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis 1990; 162:1291-7.
4. 4. Henry JL, Jaikaran ES, Davies JR. A study of polio vaccination in infancy: excretion following challenge with live virus by children given killed or living polio vaccine. J Hyg Camb 1966; 64:105-20.
5. 5. Ogra PL, Karzon TD, Righthand F, MacGillivray M. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection. N Engl J Med 1968; 279:894-9.
6. 6. Onorata IM, Modlin JF, Marshall Mcbean A, Thoms ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J Infect Dis 1991; 163:1-6.
7. 7. Tangermann RH, Aylward B, Birmingham M, et al. Current status of the global eradication of poliomyelitis. World Health Stat Q 1997; 50:188-94.
8. 8. Hexham JM, Carayannopoulos L, Capra JD. Structure and function in IgA. Chem Immunol 1997; 65:73-87.
9. 9. Mendelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989; 56:855-65.
10. 10. Abe S, Ota Y, Koike S, et al. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virology 1995; 206:1075-83.
11. 11. Horie H, Koike S, Kurate T, et al. Transgenic mice carrying the human poliovirus receptor: new animal model for study of poliovirus neurovirulence. J Virol 1994; 68:681-8.
12. 12. Koike S, Taya C, Kurata T, et al. Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci USA 1991; 88:951-5.
13. 13. Koike S, Taya C, Aoki J, et al. Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene: influence of the transgenic expression on pathogenesis. Arch Virol 1994; 139:351-63.
14. + Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J Exp Med 1995; 181:1285-92.
15. 15. World Health Organization. Maintenance and distribution of transgenic mice susceptible to human viruses. Bull World Health Organ 1993; 71:497-502.
16. 16. Koike S, Horie H, Ise I, et al. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J 1990; 9:3217-24.
17. 17. World Health Organization. Manual for the virological investigation of polio. Geneva, Switzerland: Expanded Programme on Immunization, Global Programme for Vaccines and Immunization, WHO, 1997; document CH-1211.
18. 18. Koike S, Horie H, Sato Y, et al. Poliovirus-sensitive transgenic mice as a new animal model. Dev Biol Stand 1993; 78:101-7.
19. 19. Elson CO, Ealding W, Lefkowitz J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J Immunol Methods 1984; 67:101-8.
20. 20. Souvras M, Montagnon B, Fanget B, van Wezel AL, Hazendonk AG. Direct enzyme linked immunosorbent assay (ELISA) for quantitation of poliomyelitis D-antigen. Dev Biol Stand 1980; 46:197-202.
21. 21. Nomoto A, Koike S, Aoki J. Tissue tropism and species specificity of poliovirus infection. Trends Microbiol 1994; 2:47-51.
22. 22. Zhang S, Racaniello VR. Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut. J Virol 1997; 71:4915-20.
23. 23. Racaniello VR, Ren R. Transgenic mice and the pathogenesis of poliomyelitis. Arch Virol Suppl 1994; 9:79-86.
24. 24. Etchart N, Wild F, Kaiserlian D. Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus. J Gen Virol 1996; 77:2471-8.
25. 25. Holmgren J. Mucosal immunity and vaccination. FEMS Microbiol Immunol 1991; 89:1-9.
26. 26. Liang X, Lamm ME, Nedrud JG. Oral administration of cholera toxin Sensai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J Immunol 1988; 141:1495-501.
27. 27. Sisinski P, Rowinski J, Warchol JB, et al. Poliovirus enters the human host through intestinal M-cells. Gastroenterology 1990; 98:56-8.
28. 28. Eberle KE, Nguyen VT, Freistadt MS. Low levels of poliovirus replication in primary human monocytes: possible interactions with lymphocytes. Arch Virol 1995; 140:2135-50.
29. 29. Sminia T, Soesato M, Ghutron M, Thepen T. The migration of peritoneal cells towards the gut. In: Mestecky J, Russell MW, Jackson S, Michalek SM, Tlaskalová Hogenová H, Sterzl J, eds. Advances in mucosal immunology. New York: Plenum, 1995:61-5.
30. 30. Donze HH, Lue C, Julian A, Kutteh WH, Kantele A, Mestecky J. Human peritoneal B-1 cells and the influence of continuous ambulatory peritoneal dialysis on peritoneal and peripheral blood mononuclear cell (PBMC) composition and immunoglobulin levels. Clin Exp Immunol 1997; 109: 356-61.
31. 31. Murakami M, Honjo T. Involvement of B-1 cells in mucosal immunity and autoimmunity. Immunol Today 1995; 16:534-8.
32. 32. Kroese FG, Butcher EC, Stall AM, Herzenberg LA. A major peritoneal reservoir of precursors for intestinal IgA: plasma cells. Immunol Invest 1989; 18:47-58.
33. 33. Kroese GGM, Butcher EC, Stall AM, Lalor PA, Adams S, Herzenberg LA. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int Immunol 1989; 1: 75-84.
34. 34. Lamm ME. Interaction of antigen and antibodies at mucosal surfaces. Annu Rev Microbiol 1997; 51:311-40.
35. 35. Mazanec MB, Coudret CL, Fletcher DR. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 1995; 69:1339-43.
36. 36. Fiore L, Ridolfi B, Genovese D, et al. Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies. J Virol 1997; 71:6905-12.
37. 37. Schirmbeck R, Böhm W, Melber K, Reimann J. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class 1 restricted epitope presentation. J Immunol 1995; 155: 4676-84.
38. 38. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules, Annu Rev Immunol 1997; 15:821-50.
39. 39. Coffin SE, Klinek M, Offit PA. Induction of virus-specific antibody production by lamina propria lymphocytes following intramuscular inoculation with rotavirus. J Infect Dis 1995; 172:874-8.
40. 40. Kaetzel CS, Robinson JK, Lamm ME. Epithelial transcytosis of monomeric IgA. A role for monomeric antibodies in the mucosal immune system. J Immunol 1994; 152:72-6.
41. 41. Wagner DK, Clements ML, Reimer CB, Snyder M, Nelson DL, Murphy BR. Analysis of immunoglobulin G antibody responses after administration of live and inactivated A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum. J Clin Microbiol 1987;25: 559-62.
42. 42. Ghendon Y, Robertson SE. Interruption the transmission of wild polioviruses with vaccines: immunological considerations. Bull World Health Organ 1994; 72:973-83.